Table 5 Literature review of significant inflammatory prognostic factors for overall survival or disease-free survival on multivariate analysis
Study (Ref.) | No. | Site | Treatment (No.) | Prognostic factors |
|---|---|---|---|---|
Nakamura [19] | 102 | All | OP (100) or RT (2) ± CXT (15) | CRP (≤0.3 vs. > 0.3 mg/dL) |
Szkandera [20] | 304 | All | OP (111) or OP + RT (193) ± CXT (39) | CRP (< 0.69 vs. ≥0.69 mg/dL) |
Choi [21] | 162 | Extremity | OP (90) or OP + RT (72) ± CXT (43) | ESR (≤10 vs. > 10 mm/h) |
|  |  |  |  | CRP (≤0.2 vs. > 0.2 mg/dL) |
Szkandera [22] | 260 | All | OP (93) or OP + RT (167) ± CXT (35) | NLR (< 3.58 vs. ≥3.58) |
Idowu [23] | 83 | All | OP (55) or OP + RT (28) ± CXT (6) | NLR (< 5 vs. ≥5) |
This study | 99 | Extremity | OP + RT (58) ± CXT (41) | ESR (≤15 vs. > 15 mm/h) |